Jonathan Buisson
MFRPSII, MRPharmS
Weybridge, England
Jonathan Buisson trained as a pharmacist and started his career in the pharmaceutical industry at Bayer UK. He then spent nine years at The Pharmaceutical Journal, reporting on news, politics, and business in British pharmacy and healthcare. For the past 20 years, Jonathan has worked on a wide variety of health policy, service development, retail policy, and public affairs roles at the head offices of Alliance Pharmacy, Alliance Boots, and Walgreens Boots Alliance. Following the demerger of Alliance Healthcare and its acquisition by Amerisource Bergen (now Cencora) in 2021, he has focused on European Public Affairs in Brussels and supporting AH’s European pharmacy, wholesale, and 3PL businesses in nine key markets.
Jonathan was an early adopter of the EU Falsified Medicines Directive (FMD), working to influence its adoption and implementation across WBA from 2014 onwards, as well as serving on the UK’s FMD Ministerial Advisory Board and the UK Community Pharmacy Working Group for FMD, where he was the Communications Lead. He is still involved with FMD, serving as one of the European Healthcare Distribution Association (GIRP) representatives on the EMVO Technical Advisory Group (TEAG) and a frequent attendee at EMVO events and meetings.